Myelodysplastic Syndromes

Showing NaN - NaN of 34

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDS Trial in Worldwide (Tamibarotene + Azacitidine, Tamibarotene Matched Placebo + Azacitidine)

Recruiting
  • Myelodysplastic Syndromes
  • Tamibarotene + Azacitidine
  • Tamibarotene Matched Placebo + Azacitidine
  • Tucson, Arizona
  • +87 more
Feb 2, 2023

Acute Myeloid Leukemia, MDS Trial in United States (SL-172154)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Duarte, California
  • +12 more
Jan 23, 2023

MDS Trial in Worldwide (MBG453, Placebo, Hypomethylating agents)

Active, not recruiting
  • Myelodysplastic Syndromes
  • Duarte, California
  • +46 more
Jan 20, 2023

MDS Trial in Worldwide (Magrolimab, Azacitidine, Placebo)

Active, not recruiting
  • Myelodysplastic Syndromes
  • Magrolimab
  • +2 more
  • Birmingham, Alabama
  • +168 more
Dec 7, 2022

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, MDS Trial in Canada, United States (ASTX727)

Enrolling by invitation
  • Acute Myeloid Leukemia
  • +2 more
  • Fountain Valley, California
  • +28 more
Nov 18, 2022

Relapsed or Refractory Acute Myeloid Leukemia (AML), Untreated AML, Other IDH1-mutated Positive Hematologic Malignancies Trial

Recruiting
  • Relapsed or Refractory Acute Myeloid Leukemia (AML)
  • +3 more
  • Birmingham, Alabama
  • +26 more
Sep 12, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoma Trial in United States (biological, drug, procedure)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • BPX-501 dose 1
  • +5 more
  • Atlanta, Georgia
  • +7 more
Jul 10, 2022

Acute Myeloid Leukemia, MDS, Glioblastoma Multiforme Trial in United States (DSP-7888 Dosing Emulsion)

Completed
  • Acute Myeloid Leukemia
  • +8 more
  • DSP-7888 Dosing Emulsion
  • Denver, Colorado
  • +7 more
Apr 4, 2022

MDS, Secondary Acute Myeloid Leukemia (AML) Trial in United States (Clofarabine)

Completed
  • Myelodysplastic Syndromes
  • Secondary Acute Myeloid Leukemia (AML)
  • Chicago, Illinois
  • +5 more
Mar 15, 2022

MDS Trial in United States (Pracinostat, Azacitidine)

Terminated
  • Myelodysplastic Syndromes
  • Duarte, California
  • +24 more
Feb 4, 2022

Hematologic Malignancy, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Canada, United States (CPX-351)

Completed
  • Hematologic Malignancy
  • +4 more
  • Washington, District of Columbia
  • +12 more
Jul 20, 2021

Connect® Myeloid Disease Registry

Recruiting
  • Primary Myelofibrosis
  • +2 more
    • Huntsville, Alabama
    • +228 more
    Mar 30, 2021

    MDS Trial in Canada, United States (anti-thymocyte globulin)

    Completed
    • Myelodysplastic Syndromes
    • anti-thymocyte globulin
    • Washington, District of Columbia
    • +27 more
    Jan 24, 2021

    MDS, Refractory Anemia With Excess Blasts, Chronic Myelomonocytic Leukemia Trial in Worldwide (rigosertib sodium)

    Completed
    • Myelodysplastic Syndromes
    • +3 more
    • rigosertib sodium
    • Stanford, California
    • +34 more
    Jun 29, 2020

    MDS, MDS, RAEB Trial in Worldwide (ON 01910.Na)

    Completed
    • Myelodysplastic Syndromes
    • +3 more
    • ON 01910.Na
    • Scottsdale, Arizona
    • +86 more
    Jun 29, 2020

    MDS Trial in United States (azacitidine)

    Completed
    • Myelodysplastic Syndromes
    • Bakersfield, California
    • +30 more
    Nov 7, 2019

    MDS, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in United States (oral azacitidine)

    Completed
    • Myelodysplastic Syndromes
    • +2 more
    • oral azacitidine
    • La Jolla, California
    • +7 more
    Nov 7, 2019

    Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)

    Completed
    • Leukemia
    • +4 more
    • therapeutic allogeneic lymphocytes
    • +6 more
    • Denver, Colorado
    • +13 more
    Sep 13, 2019

    Leukemia, MDS, Blastic Plasmacytoid Dendritic Cell Tumor Trial in Dallas (DT388IL3)

    Completed
    • Leukemia
    • +2 more
    • Dallas, Texas
      UT Southwestern Medical Center
    Mar 29, 2019

    Bone Marrow and Blood Samples From Leukemia or Other

    Completed
    • Leukemia
    • +2 more
    • cytogenetic analysis
    • fluorescence in situ hybridization
    • Mobile, Alabama
    • +279 more
    Mar 5, 2015

    S9910, Collecting and Storing Blood and Bone Marrow Samples From

    Completed
    • Leukemia
    • +2 more
    • biologic sample preservation procedure
    • Ft. Smith, Arkansas
    • +291 more
    Mar 5, 2015

    Chronic Myeloproliferative Disorders, Leukemia, MDS Trial in United States (ruxolitinib phosphate, laboratory biomarker

    Completed
    • Chronic Myeloproliferative Disorders
    • +4 more
    • ruxolitinib phosphate
    • +2 more
    • Birmingham, Alabama
    • +23 more
    Oct 22, 2014

    Children With Soft Tissue Sarcoma or Rhabdomyosarcoma

    Completed
    • Leukemia
    • +2 more
    • clonality analysis
    • +2 more
    • Downey, California
    • +95 more
    Aug 4, 2014

    Leukemia, MDS Trial in Australia, Canada, United States (asparaginase, cytarabine, gemtuzumab ozogamicin)

    Completed
    • Leukemia
    • Myelodysplastic Syndromes
    • Birmingham, Alabama
    • +75 more
    Feb 18, 2014